Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 1 | 1 | — | — | — | 1 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | 1 | — | — | — | 1 |
Infections | D007239 | EFO_0000544 | — | 1 | 1 | — | — | — | 1 |
Hepatitis c | D006526 | — | B19.2 | 1 | 1 | — | — | — | 1 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | 1 | 1 | — | — | — | 1 |
Hepatitis | D006505 | — | K75.9 | 1 | 1 | — | — | — | 1 |
Chronic hepatitis | D006521 | — | K73.9 | 1 | 1 | — | — | — | 1 |
Hepatitis a | D006506 | EFO_0007305 | B15 | 1 | 1 | — | — | — | 1 |
Drug common name | PIDILIZUMAB |
INN | pidilizumab |
Description | Pidilizumab (humanized mab) |
Classification | Antibody |
Drug class | vasodilators (undefined group); monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108680 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | B932PAQ1BQ (ChemIDplus, GSRS) |